111 related articles for article (PubMed ID: 10199787)
21. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
22. Structural characterization of the skin glycosaminoglycans in patients with pseudoxanthoma elasticum.
Maccari F; Volpi N
Int J Dermatol; 2008 Oct; 47(10):1024-7. PubMed ID: 18986348
[TBL] [Abstract][Full Text] [Related]
23. [Serum glycosaminoglycans in Graves' disease patients].
Winsz-Szczotka KB; Olczyk KZ; Koźma EM; Komosińska-Vassev KB; Wisowski GR; Marcisz C
Wiad Lek; 2006; 59(1-2):66-71. PubMed ID: 16646296
[TBL] [Abstract][Full Text] [Related]
24. Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens.
Otto EA; Ochs K; Hansen C; Wall JR; Kahaly GJ
J Clin Endocrinol Metab; 1996 Aug; 81(8):3045-50. PubMed ID: 8768872
[TBL] [Abstract][Full Text] [Related]
25. Plasma leptin concentrations in patients with Graves' disease with or without ophthalmopathy.
Ozata M; Uckaya G; Bolu E; Corapcioglu D; Bingol N; Ozdemir IC
Med Sci Monit; 2001; 7(4):696-700. PubMed ID: 11433197
[TBL] [Abstract][Full Text] [Related]
26. Glycosaminoglycans in pterygium tissues and normal conjunctiva.
Kaneko M; Takaku I; Katsura N
Jpn J Ophthalmol; 1986; 30(2):165-73. PubMed ID: 3761740
[TBL] [Abstract][Full Text] [Related]
27. Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy.
Chen MH; Chen MH; Liao SL; Chang TC; Chuang LM
Clin Endocrinol (Oxf); 2008 Aug; 69(2):332-7. PubMed ID: 18284633
[TBL] [Abstract][Full Text] [Related]
28. Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis.
Volpi N
Anal Biochem; 1999 Sep; 273(2):229-39. PubMed ID: 10469494
[TBL] [Abstract][Full Text] [Related]
29. A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy.
Campi I; Vannucchi GM; Minetti AM; Dazzi D; Avignone S; Covelli D; Currò N; Ratiglia R; Guastella C; Pignataro L; Beck-Peccoz P; Salvi M
Ophthalmology; 2013 May; 120(5):1092-8. PubMed ID: 23399378
[TBL] [Abstract][Full Text] [Related]
30. Glycosaminoglycans of the human trabecular meshwork in primary open-angle glaucoma.
Knepper PA; Goossens W; Hvizd M; Palmberg PF
Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1360-7. PubMed ID: 8641839
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix changes in urethral stricture disease.
Da-Silva EA; Sampaio FJ; Dornas MC; Damiao R; Cardoso LE
J Urol; 2002 Aug; 168(2):805-7. PubMed ID: 12131371
[TBL] [Abstract][Full Text] [Related]
32. Glycosaminoglycan antibodies in endocrine ophthalmopathy.
Kahaly G; Hansen CE; Stover C; Beyer J; Otto E
Horm Metab Res; 1993 Dec; 25(12):637-9. PubMed ID: 8119669
[TBL] [Abstract][Full Text] [Related]
33. Cytokines in the evolution of Graves' ophthalmopathy.
Natt N; Bahn RS
Autoimmunity; 1997; 26(2):129-36. PubMed ID: 9546815
[TBL] [Abstract][Full Text] [Related]
34. Modulation of cellular functions in retroorbital fibroblasts using antisense oligonucleotides targeting the c-myc protooncogene.
Heufelder AE; Bahn RS
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1420-32. PubMed ID: 7775120
[TBL] [Abstract][Full Text] [Related]
35. Antioxidant activity and structural modifications of serum chondroitin sulfate in Graves' disease.
Winsz-Szczotka K; Komosińska-Vassev K; Kuźnik-Trocha K; Olczyk K
Clin Biochem; 2014 Jan; 47(1-2):19-24. PubMed ID: 23954851
[TBL] [Abstract][Full Text] [Related]
36. Content and synthesis of glycosaminoglycans in the developing lung.
Horwitz AL; Crystal RC
J Clin Invest; 1975 Nov; 56(5):1312-8. PubMed ID: 127004
[TBL] [Abstract][Full Text] [Related]
37. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs.
Cozma I; Zhang L; Uddin J; Lane C; Rees A; Ludgate M
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1630-5. PubMed ID: 17848636
[TBL] [Abstract][Full Text] [Related]
38. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
[TBL] [Abstract][Full Text] [Related]
39. Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy.
Aniszewski JP; Valyasevi RW; Bahn RS
J Clin Endocrinol Metab; 2000 Feb; 85(2):776-80. PubMed ID: 10690890
[TBL] [Abstract][Full Text] [Related]
40. Glycosaminoglycan modifications in Duchenne muscular dystrophy: specific remodeling of chondroitin sulfate/dermatan sulfate.
Negroni E; Henault E; Chevalier F; Gilbert-Sirieix M; Van Kuppevelt TH; Papy-Garcia D; Uzan G; Albanese P
J Neuropathol Exp Neurol; 2014 Aug; 73(8):789-97. PubMed ID: 25003237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
